Author response for "Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain"

Clara Mazagatos, The SARI Sentinel Surveillance RSV Study Group, Mercedes Rumayor et al.|Unknown|2024

Cited by 0